Welton O'neal Pharm. D
About Welton O'neal Pharm. D
Welton O'neal, Pharm. D, serves as the Executive Director and Head of Medical Affairs at Supernus Pharmaceuticals, where he has worked since 2012. He previously held a position as Vice President of Medical Advocacy and Development at Bristol-Myers Squibb for 14 years and has extensive experience in the CNS specialty field.
Current Role at Supernus Pharmaceuticals
Welton O'neal serves as the Executive Director and Head of Medical Affairs at Supernus Pharmaceuticals, Inc. since 2012. In this role, he has developed the Medical Affairs Department and has been actively involved in the CNS specialty field. He reports directly to the Chief Medical Officer, contributing to the strategic direction of medical initiatives within the company. His leadership in medical affairs supports the company's mission to advance treatments in central nervous system disorders.
Previous Experience at Bristol-Myers Squibb
Prior to his current position, Welton O'neal worked at Bristol-Myers Squibb for 14 years, from 1987 to 2001. He held the position of Vice President of Medical Advocacy and Development. His experience at this major pharmaceutical company provided him with extensive knowledge in medical strategy and advocacy, which he later applied in his role at Supernus Pharmaceuticals.
Educational Background in Pharmacy
Welton O'neal has a comprehensive educational background in pharmacy. He completed his Doctor of Pharmacy (PharmD) at the University of Kentucky College of Pharmacy from 1980 to 1981. He also completed a General Hospital Pharmacy Residency from 1979 to 1980. Additionally, he studied Pediatrics during a Post-PharmD Clinical Residency. His foundational education includes a Bachelor's degree in Science from Presbyterian College, which he obtained from 1972 to 1976, and another Bachelor's degree in Pharmacy from the Medical University of South Carolina from 1976 to 1979.
Specialization in CNS Field
In his current role at Supernus Pharmaceuticals, Welton O'neal has focused on the central nervous system (CNS) specialty field. His expertise in this area has been instrumental in developing medical strategies that address the needs of patients with CNS disorders. His involvement in this specialty reflects his commitment to advancing medical knowledge and improving treatment outcomes.